-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Mirum Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2019 to Q1 2025.
- Mirum Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$1.96M, a 113% decline year-over-year.
- Mirum Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $10.3M.
- Mirum Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$70.9M, a 40.9% increase from 2022.
- Mirum Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$120M, a 9.51% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)